We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is BRBR Stock Attractive After Its Sharp Valuation Reset in 2026?
Read MoreHide Full Article
Key Takeaways
BRBR trades below industry, sector and historical valuation levels after a sharp 2026 stock decline.
BellRing Brands cut 2026 sales and EBITDA guidance amid weaker demand, promotions and higher costs.
BRBR benefits from protein demand, distribution gains, innovation and remaining share repurchase capacity.
BellRing Brands, Inc. BRBR has seen a sharp valuation reset in 2026 as investors weigh weaker guidance, falling margins and a less certain earnings recovery. The stock’s lower multiple now reflects a more cautious view of the business.
The question is whether that discount adequately compensates investors for execution risks tied to promotions, input costs, freight, mix and the timing of margin improvement.
BRBR Trades Below Key Valuation Benchmarks
BRBR trades at 10.2X forward 12-month earnings, below 14.58X for its Zacks sub-industry, 17.0X for the broader Zacks Consumer Staples sector and 20.2X for the S&P 500 index.
The discount also looks large against the company’s own history. BellRing shares trade well below the stock’s five-year median forward earnings multiple, after falling 51.1% year to date and 76.5% over the trailing 12-month period.
Image Source: Zacks Investment Research
BellRing Brands’ Guidance Reset Raises Risk
Management lowered fiscal 2026 net sales guidance to $2.33-$2.37 billion, or flat to 2% growth. The prior outlook called for $2.41-$2.46 billion, or 4% to 6% growth.
The adjusted EBITDA outlook was cut to $315-$335 million from $425-$440 million. The revision reflects weaker Premier Protein baseline velocities, more muted demand-driver contribution, unfavorable mix, increased trade investment, freight and protein inflation, lower cost savings and reduced selling, general and administrative expense leverage.
BellRing’s fiscal second-quarter earnings showed why the valuation reset alone may not settle the investment debate. Adjusted earnings fell 74% to 14 cents, while adjusted EBITDA declined 55% to $53.8 million.
Adjusted EBITDA margin fell to 9% from 20.2% a year earlier. Premier Protein volumes rose 11%, primarily from promotions and distribution gains, but average net selling prices declined because of promotional investment and unfavorable mix.
That matters for investors assessing sales quality. Volume growth can protect category relevance, but it does not necessarily rebuild earnings if it depends heavily on discounts while costs remain elevated.
BRBR needs better pricing, mix and cost control to convert demand into stronger margins. Until that happens, earnings recovery could lag the company’s top-line opportunity.
BellRing Brands Retains Long-Term Support
The risk case is balanced by solid long-term demand drivers. BellRing operates in a protein category that remains healthy, with ready-to-drink shakes still benefiting from mainstream wellness trends and retailer support.
Distribution also remains a positive. Premier Protein consumption outside club rose 15% in the fiscal second quarter, while mass, food and eCommerce generated high-teens growth. Innovation through Premier Protein Ultimate and Premier Protein Sparkling Soda adds potential new use cases and shelf opportunities.
The Simply Good Foods Company (SMPL - Free Report) is a relevant active-nutrition comparison because its Atkins and Quest brands compete for health-and-wellness consumer spending. Celsius Holdings, Inc. (CELH - Free Report) , a functional beverage company with CELSIUS and Alani Nu, also shows how wellness-oriented beverage brands are competing for consumer routines and retail space.
Capital allocation provides another support point. BellRing had $516.9 million remaining under its share-repurchase authorization as of March 31, 2026. Management expects strong cash flow in the second half of 2026 and net leverage in the low 3X range for the remainder of the fiscal year.
Image Source: Zacks Investment Research
BRBR’s Valuation Signal Remains Mixed
The bottom line is that BRBR’s lower multiple improves the valuation setup, but it does not erase execution risk. The company still needs to show that category demand, distribution and innovation can translate into better earnings quality.
The current Zacks Rank and individual Style Scores are not specified for BRBR. In general, the Zacks Rank is most useful for evaluating estimate-revision momentum, while Style Scores help investors assess value, growth and momentum characteristics alongside that rank.
For BRBR, the Neutral view and $14 price target point to a balanced risk-reward profile rather than a clear bullish signal. Discounted multiples may attract attention, but weaker visibility around margins and earnings recovery keeps the valuation message mixed.
View the Zacks #1 Rank List
Image: Bigstock
Is BRBR Stock Attractive After Its Sharp Valuation Reset in 2026?
Key Takeaways
BellRing Brands, Inc. BRBR has seen a sharp valuation reset in 2026 as investors weigh weaker guidance, falling margins and a less certain earnings recovery. The stock’s lower multiple now reflects a more cautious view of the business.
The question is whether that discount adequately compensates investors for execution risks tied to promotions, input costs, freight, mix and the timing of margin improvement.
BRBR Trades Below Key Valuation Benchmarks
BRBR trades at 10.2X forward 12-month earnings, below 14.58X for its Zacks sub-industry, 17.0X for the broader Zacks Consumer Staples sector and 20.2X for the S&P 500 index.
The discount also looks large against the company’s own history. BellRing shares trade well below the stock’s five-year median forward earnings multiple, after falling 51.1% year to date and 76.5% over the trailing 12-month period.
Image Source: Zacks Investment Research
BellRing Brands’ Guidance Reset Raises Risk
Management lowered fiscal 2026 net sales guidance to $2.33-$2.37 billion, or flat to 2% growth. The prior outlook called for $2.41-$2.46 billion, or 4% to 6% growth.
The adjusted EBITDA outlook was cut to $315-$335 million from $425-$440 million. The revision reflects weaker Premier Protein baseline velocities, more muted demand-driver contribution, unfavorable mix, increased trade investment, freight and protein inflation, lower cost savings and reduced selling, general and administrative expense leverage.
BellRing currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
BRBR Earnings Show Significant Compression
BellRing’s fiscal second-quarter earnings showed why the valuation reset alone may not settle the investment debate. Adjusted earnings fell 74% to 14 cents, while adjusted EBITDA declined 55% to $53.8 million.
Adjusted EBITDA margin fell to 9% from 20.2% a year earlier. Premier Protein volumes rose 11%, primarily from promotions and distribution gains, but average net selling prices declined because of promotional investment and unfavorable mix.
That matters for investors assessing sales quality. Volume growth can protect category relevance, but it does not necessarily rebuild earnings if it depends heavily on discounts while costs remain elevated.
BRBR needs better pricing, mix and cost control to convert demand into stronger margins. Until that happens, earnings recovery could lag the company’s top-line opportunity.
BellRing Brands Retains Long-Term Support
The risk case is balanced by solid long-term demand drivers. BellRing operates in a protein category that remains healthy, with ready-to-drink shakes still benefiting from mainstream wellness trends and retailer support.
Distribution also remains a positive. Premier Protein consumption outside club rose 15% in the fiscal second quarter, while mass, food and eCommerce generated high-teens growth. Innovation through Premier Protein Ultimate and Premier Protein Sparkling Soda adds potential new use cases and shelf opportunities.
The Simply Good Foods Company (SMPL - Free Report) is a relevant active-nutrition comparison because its Atkins and Quest brands compete for health-and-wellness consumer spending. Celsius Holdings, Inc. (CELH - Free Report) , a functional beverage company with CELSIUS and Alani Nu, also shows how wellness-oriented beverage brands are competing for consumer routines and retail space.
Capital allocation provides another support point. BellRing had $516.9 million remaining under its share-repurchase authorization as of March 31, 2026. Management expects strong cash flow in the second half of 2026 and net leverage in the low 3X range for the remainder of the fiscal year.
Image Source: Zacks Investment Research
BRBR’s Valuation Signal Remains Mixed
The bottom line is that BRBR’s lower multiple improves the valuation setup, but it does not erase execution risk. The company still needs to show that category demand, distribution and innovation can translate into better earnings quality.
The current Zacks Rank and individual Style Scores are not specified for BRBR. In general, the Zacks Rank is most useful for evaluating estimate-revision momentum, while Style Scores help investors assess value, growth and momentum characteristics alongside that rank.
For BRBR, the Neutral view and $14 price target point to a balanced risk-reward profile rather than a clear bullish signal. Discounted multiples may attract attention, but weaker visibility around margins and earnings recovery keeps the valuation message mixed.